Alvotech Acquires Xbrane’s R&D Operations, Strengthening Biosimilars
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane...